Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,258 signal articles · 52 in last 24h · 115,243 total before filter · latest 1h ago

52last 24h

1809last 7d

299● bullish (7d)

171● bearish (7d)

205publishers

All Macro322 Earnings856 M&A105 Regulatory25 Product16 Analyst25

✕ clear all filtersticker: GILDsentiment: bullishSentiment:bullish neutral bearish show all (incl. clickbait)

Insider Monkey48d agobullish

Gilead (GILD) Wins FDA Approval for Trodelvy in TNBC

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 12 Most Profitable S&P 500 Stocks to Invest In. On June 25, 2026, the Food and Drug Administration approved Trodelvy from Gilead Sciences, Inc. (NASDAQ:GILD) for two indications in adults with triple-negative breast cancer. The first approval covers sacituzumab govitecan-hziy as a single agent for the first-line […]

GILD MRK ^GSPC

Stocktwits85d agobullish

GILD Stock Jumps After Winning Accelerated FDA Approval For HDV Treatment

U.S. Food and Drug Administration (FDA) approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta virus.

GILD